5 terminated. 5 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Terminated 5 |
| Phase 2 | 1 | Terminated 1 |
Follow Malignant Solid Neoplasm: new trials by email Literature Review of Malignant Solid Neoplasm trials Research Report on Malignant Solid Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients Virus-specific Cytotoxic T-lymphocytes - Adenovirus Infection, BK Virus Infection | Phase 1 | Terminated | M.D. Anderson Cancer Center | 12 | 2023-01-06 | 2026-08-11 |
| Pharmacokinetics of Sotrovimab as Pre-exposure Prophylaxis for COVID-19 in Hematopoietic Stem Cell Transplant Recipients, COVIDMAB Study Questionnaire Administration, Sotrovimab, Biospecimen Collection - COVID-19 Infection, Hematopoietic and Lymphoid Cell Neoplasm | Phase 1 | Terminated | Fred Hutchinson Cancer Center | 20 | 2022-01-25 | 2025-02-13 |
| Rintatolimod and IFN Alpha-2b for the Treatment of COVID-19 in Cancer Patients Recombinant Interferon Alfa-2b, Rintatolimod - Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm | Phase 1 / Phase 2 | Terminated | Roswell Park Cancer Institute | 4 | 2020-11-17 | 2026-01-13 |
| Nozin in Preventing Respiratory Viral Infections in Patients Undergoing Stem Cell Transplant, PREV-NOSE STUDY Nozin, Best Practice - Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm | Phase 1 | Terminated | Fred Hutchinson Cancer Center | 10 | 2019-09-03 | 2024-11-08 |
| Genetically Modified T-Cell Therapy in Treating Patients With Advanced ROR1+ Malignancies Laboratory Biomarker Analysis, ROR1 CAR-specific Autologous T-Lymphocytes - Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm | Phase 1 | Terminated | Fred Hutchinson Cancer Center | 21 | 2016-03-16 | 2022-08-31 |
Hematologic Neoplasms (5) · Adenoviridae Infections (1) · COVID-19 (1) · Carcinoma, Non-Small-Cell Lung (1) · Cytomegalovirus Infections (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Lymphoma, Mantle-Cell (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Triple Negative Breast Neoplasms (1)
Hematologic Diseases (5) · Hemic and Lymphatic Diseases (5) · Neoplasms (5) · Neoplasms by Site (5) · Infections (2) · Lung Diseases (2) · Respiratory Tract Diseases (2) · Virus Diseases (2) · Breast Diseases (1) · Breast Neoplasms (1) · Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Chronic Disease (1) · Coronaviridae Infections (1) · Coronavirus Infections (1)
Interferon alpha-2 (1) · Introns (1) · Practice Guidelines as Topic (1) · Specimen Handling (1) · Standard of Care (1) · poly(I).poly(c12,U) (1) · sotrovimab (1)
Fred Hutchinson Cancer Center (3) · M.D. Anderson Cancer Center (1) · Roswell Park Cancer Institute (1)
United States (5)
Alpana Waghmare (1) · David Maloney (1) · Igor Puzanov (1) · May Daher, MD (1) · Steven Pergam (1)
P30CA016056 (1), R01CA114536 (1)